Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
CCCC logo

CCCC

NGS
C4 Therapeutics Inc.
ManufacturingBiological Product (except Diagnostic) Manufacturing
Watchlists:
Last updated: Monday 14th July 2025
2.23
+0.24 (12.06%)
Prev Close:1.99
Open:1.97
Bid:2.25
Ask:2.3
52 Week Range
1.09
7.66
Volume:1,279,291
Mkt Cap:121 M
Price Target
$2.56
+14.8%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

CCCC - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Invalid date
Depreciation And Amortization1 M2 M2 M1 M2 M
General And Administrative Expense42 M42 M43 M33 M15 M
Gross Profit Margin (profit Margin After CGS)36 M21 M31 M46 M
Interest Expense Non Operating1000000.02 M2 M1 M
Misc Other Special Charges14 M-600000.0-2 M-2 M26 M
Net Income (loss)-105 M-132 M-128 M-84 M-66 M
Net Income Common Stockholders-105 M-132 M-128 M-84 M-66 M
Net Income Continuous Operations-105 M-132 M-128 M-84 M-66 M
Net Non Operating Interest Income Expense14 M10 M-1 M387000.0393000.0
Normalized Income-102 M
Operating Income-120 M-139 M-130 M-82 M-60 M
Operating Income Before Depreciation (EBITDA)-97 M-122 M-124 M-80 M-64 M
Operating Expense155 M160 M161 M128 M94 M
Other Gand A42 M42 M43 M33 M15 M
Other Operating Expenses155 M160 M11 M4 M
Research Expense111 M118 M118 M95 M78 M
Restructring And Mn A Income2 M
Salaries And Wages30 M27 M
Total Income Available For Interest Expense (EBIT)-105 M-130 M-126 M-82 M-66 M
Total Revenues36 M21 M31 M46 M
Total Expenses155 M160 M161 M128 M94 M
Total Revenue36 M21 M31 M46 M
Avgshs69 M50 M49 M46 M11 M
Avgshsdt69 M50 M49 M11 M
Basiceps-1.52-2.67-2.62-1.82-5.83
Basicepscont-1.52-2.67-2.62-1.82-5.83
Depamor1 M2 M2 M1 M2 M
Dileps-1.52-2.67-2.62-1.82-5.83
Dilepscont-1.52-2.67-2.62
Intinc14 M10 M4 M387000.0393000.0
Netincdisc-105 M-132 M-128 M-84 M-66 M
Othincexp-180000.0-3 M6 M3 M-26 M
Pretaxinc-105 M-131 M-128 M-85 M-67 M
Resdev111 M118 M118 M95 M78 M
Restruct2 M
Sga42 M42 M43 M33 M15 M
Shsout71 M69 M49 M49 M43 M
Specincchg-2 M
Taxprov100000.01 M-626000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader